PreDxion Bio
Stage
Seed | AliveTotal Raised
$120KLast Raised
$120K | 5 yrs agoAbout PreDxion Bio
PreDxion Bio develops MicroKine, a diagnostic tool that measures a patient's immune response. It can identify up to six cytokine proteins within 30 minutes from a drop of blood. Using this technology, physicians can tailor ICU treatment to a particular patient's needs--thereby bringing precision medicine to the ICU.
PreDxion Bio Headquarter Location
200 East Liberty Lobby
Ann Arbor, Michigan, 48103,
United States
734-436-1050
Expert Collections containing PreDxion Bio
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
PreDxion Bio is included in 3 Expert Collections, including Medical Devices.
Medical Devices
8,785 items
Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.
Health Monitoring & Diagnostics
2,394 items
Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance
Health IT
7,900 items
PreDxion Bio Web Traffic
PreDxion Bio Rank
Where is PreDxion Bio's headquarters?
PreDxion Bio's headquarters is located at 200 East Liberty Lobby, Ann Arbor.
What is PreDxion Bio's latest funding round?
PreDxion Bio's latest funding round is Seed.
How much did PreDxion Bio raise?
PreDxion Bio raised a total of $120K.
Who are the investors of PreDxion Bio?
Investors of PreDxion Bio include Y Combinator.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.